DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Andrew Dudum - 6 Dudum - 5 Michael Siluk - 1 Gray Beard - 1 She'd - 1 that's - 1 Beard - 1 wouldn't - 1
Top related locs:
U.S Charlotte , North Carolina Dudley , North Tyneside Britain Collegeville , Pennsylvania Hims Israel Gaza
Top related orgs:
Novo Nordisk - 2 CNBC - 2 — Novo - 1 UCG - 1 Teladoc Health - 1 World Health Organization - 1 Food - 1 WeightWatchers Clinic - 1

Search resuls for: "Andrew Dudum"


8 mentions found


☆ How digital health companies are capitalizing on the GLP-1 boom
  + stars: | 2024-05-25 | by ( Annika Kim Constantino Ashley Capoot | Annika Kim Constantino | Ashley Capoot | ) www.cnbc.com   time to read: +14 min
In addition to Wegovy and Ozempic, the GLP-1 class includes Eli Lilly's highly popular weight loss drug Zepbound and diabetes treatment Mounjaro. VanGilder signed up nearly four years ago and started taking the weekly diabetes injection Ozempic specifically for weight loss. The big difference between Calibrate and prior weight loss efforts, VanGilder said, is that she doesn't feel like she's dieting. Calibrate is one of the only companies to regularly release reports detailing the results of its weight loss program. The federal Medicare program by law can't cover weight loss drugs unless the prescription is for another approved health benefit, such as diabetes or cardiovascular health.
Persons: Michael Siluk, Gray Beard, She'd, that's, Beard, wouldn't, She's, Ro, Goldman Sachs, Eli Lilly's, it's, Andrew Dudum, There's, Zachariah Reitano, Reitano, Wegovy, WeightWatchers, Gary Foster, Foster, Oprah Winfrey's, Kim Gradwell, Lee Smith, Jennifer VanGilder, she'd, Jenny Craig, VanGilder, I've, Kristin Baier, Rob MacNaughton, Ro's Reitano, we'd, Eli Lilly, Craig Primack, Primack, Hims, Dudum, We're Organizations: — Novo, UCG, Novo Nordisk, CNBC, Teladoc Health, World Health Organization, Food, WeightWatchers Clinic, Ursinus College, Asset Management Locations: Charlotte , North Carolina, U.S, Dudley , North Tyneside, Britain, Collegeville , Pennsylvania, Hims
☆ Hims & Hers Health adds compounded GLP-1 injections to weight loss program
  + stars: | 2024-05-20 | by ( Ashley Capoot Brandon Gomez | Ashley Capoot | In | ) www.cnbc.com   time to read: +2 min
Digital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections, the company announced Monday. The company, which offers a range of direct-to-consumer treatments for conditions like erectile dysfunction and hair loss, launched a weight loss program in December. But GLP-1 medications — the class of drugs like Ozempic and Wegovy that have skyrocketed in popularity — were not previously offered as part of that program. Customers can access the compounded GLP-1 medications via a prescription from a licensed healthcare providers on the Hims & Hers platform. The company's oral medication kits start at $79 a month, and its compounded GLP-1 injections will start at $199 a month.
Persons: Andrew Dudum, Dudum Organizations: Novo Nordisk, FDA, U.S . Food, Drug Administration, CNBC, & $ Locations: U.S
☆ 'Shark Tank' host Kevin O'Leary says he would've fired this CEO in 'seconds' for backing pro-Palestinian protesters: 'Be gone'
  + stars: | 2024-05-07 | by ( Kwan Wei Kevin Tan | ) www.businessinsider.com   time to read: +4 min
Kevin O'Leary said he would've fired the Hims & Hers CEO for backing the pro-Palestinian protests. AdvertisementHims & Hers CEO Andrew Dudum should have been fired immediately for supporting the pro-Palestinian student protesters, says "Shark Tank" host and investor Kevin O'Leary. On May 1, Dudum said in an X post that student protesters should "keep going" because "it's working." People are very polarized by this war, as they are in every war," O'Leary said. Last week, the businessman said in an interview on Fox News' "The Five" that pro-Palestinian student protesters will be "screwed" when they start job hunting.
Persons: Kevin O'Leary, would've, Andrew Dudum, " O'Leary, Dudum's, —, O'Leary, Dudum, you’re, Dudum didn't, CNN's Laura Poole Organizations: Service, Palestinian, Fox Business, Columbia University, UCLA, BI, Fox News, Google, National Labor Relations Board Locations: Israel, Gaza
☆ Hims & Hers CEO Andrew Dudum talks earnings with Jim Cramer
  + stars: | 2024-02-27 | by ( Jim Cramer | ) www.cnbc.com   time to read: 1 min
Hims & Hers CEO Andrew Dudum talks earnings with Jim CramerHims & Hers Co-Founder and CEO Andrew Dudum joins 'Mad Money' host Jim Cramer to talk earnings, the healthcare space, their direct-to-consumer infrastructure and more.
Persons: Andrew Dudum, Jim Cramer Hims, Jim Cramer Organizations: & & '
☆ Hims & Hers soars 32% on rapid growth in mental health, weight loss and dermatology treatments
  + stars: | 2024-02-27 | by ( Ashley Capoot | In | ) www.cnbc.com   time to read: +3 min
The New York Stock Exchange with a Hims & Hers Health, Inc banner is pictured as a person runs past in the Manhattan borough of New York City, New York, January 21, 2021. Hims & Hers is an online platform where patients can meet with providers and get personalized support for skincare, mental health, sexual health, weight loss and hair care. For the first quarter, Hims & Hers expects revenue growth of at least 40% from a year earlier to between $267 and $272 million. He said newer specialties like weight loss, mental health and Hers Dermatology are seeing increased adoption, and could each deliver more than $100 million in revenue in 2025. WATCH: Ro CEO on telehealth and the impact of weight loss drugs
Persons: They're, Andrew Dudum, Dudum, Jefferies Organizations: New York Stock Exchange, Revenue, Jefferies, Deutsche Bank Locations: Manhattan, New York City , New York
☆ Why Hims & Hers won't prescribe Ozempic for now in its new weight-loss program
  + stars: | 2023-11-27 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +2 min
When Hims & Hers launches its new weight-loss program, the digital-health company won't be joining in on the Ozempic craze, its CEO, Andrew Dudum, said. While pricey drugs like Ozempic and Wegovy have exploded in popularity this year for their potential to help people lose weight, Hims & Hers plans to offer cheaper generic medications for weight loss, at least initially. Ro's weight-loss program was fueling fast growth for the startup this year, but some patients struggled with insurance denials and delays in communication with Ro. Dudum said during the company's third-quarter earnings call that Hims & Hers expected weight management to be "an extraordinarily valuable category." Next year, in addition to launching its weight-loss program, the company plans to expand its new AI engine, which it's been beta testing in its psychiatry patients.
Persons: Andrew Dudum, Dudum, It's Organizations: Business
☆ 3 reasons digital-healthcare pioneer Hims is staying out of the latest weight-loss craze for now
  + stars: | 2023-04-10 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +4 min
'As startups dive into prescribing hot new weight loss drugs, Hims & Hers is taking a backseat. Its CEO said Hims wants to offer GLP-1s for weight loss, but thinks it's too early. He cited challenges in the young market like insurers refusing to cover GLP-1s and drug shortages. After Hims & Hers' first profitable quarter ever, the startup is thinking about getting in on telehealth's weight-loss craze. An 'inconsistent' supply chainExploding demand for the new weight-loss drugs has also resulted in shortages, which affect all patients prescribed GLP-1s, not just those using the drugs for weight loss.
☆ Buzzy startups failed to fix mental-health care. Now their mistakes are fueling the space's next generation.
  + stars: | 2022-12-01 | by ( Blake Dodge | ) www.businessinsider.com   time to read: +13 min
In the past two years, highly funded startups have tried to disrupt mental-health care. The startups said they wanted to help solve the industry's biggest problems: Mental-health care is too expensive, and there isn't enough of it to go around. Talkspace's priority is now its division that sells mental-health care to employers, which pay recurring fees for employee access. Startups tackling more serious mental-health conditions are working with health plansThere's also a rising crop of mental-health companies tackling the costliest mental-health conditions, something the direct-to-consumer firms tend to shy away from. About half of Bicycle's patients pay with their insurance, a number he's looking to increase.
0 next >>
Total: 8